1. Home
  2. WTO vs DCOY Comparison

WTO vs DCOY Comparison

Compare WTO & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$1.08

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.97

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTO
DCOY
Founded
2008
N/A
Country
China
United States
Employees
N/A
11
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
WTO
DCOY
Price
$1.08
$6.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
207.9K
11.9K
Earning Date
03-18-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.53
52 Week High
$4.50
$9.57

Technical Indicators

Market Signals
Indicator
WTO
DCOY
Relative Strength Index (RSI) 40.80 50.88
Support Level $1.02 $4.96
Resistance Level $1.21 $9.09
Average True Range (ATR) 0.21 0.87
MACD 0.06 0.13
Stochastic Oscillator 31.37 47.05

Price Performance

Historical Comparison
WTO
DCOY

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: